Skip to main content
Premium Trial:

Request an Annual Quote

ABI and FDA Collaborate to Study Molecular Basis of Liver Toxicity of Diabetes Drugs

This article has been corrected to address an error in the last paragraph that stated that the FDA ordered the withdraw of Vioxx after safety concerns. The drug was voluntarily withdrawn.


NEW YORK, March 9 (GenomeWeb News) - Applied Biosystems is collaborating with the Food and Drug Administration to study the molecular basis of liver toxicity of diabetes drugs, ABI said today.


Working with the FDA's NationalCenterfor Toxicological Research, ABI scientists have been using the company's Expression Array system and Rat Genome Survey microarrays to study potential liver toxicity of a common class of diabetes drugs. Samples are provided by the FDA/NCTR.


Further, ABI will use its real-time PCR systems and TaqMan Gene Expression assays to validate the results and extend the study of biomarkers found to other samples. The aim is to identify specific genes and pathways associated with liver toxicity and predict toxicity of future drugs in the same chemical class.


The collaboration follows the recent formation of a Drug Safety Oversight Board by the FDA after the withdrawal of Vioxx and Tysabri over safety concerns.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.